Ilika plc Collaboration with Galvani Bioelectronics (3157Z)
14 March 2017 - 6:00PM
UK Regulatory
TIDMIKA
RNS Number : 3157Z
Ilika plc
14 March 2017
Ilika plc
("Ilika" or the "Company")
Ilika and Galvani Bioelectronics enter into collaboration in
Bioelectronics Project
Ilika (AIM: IKA), a pioneer in materials innovation and
solid-state battery technology, announces a two-year collaborative
project with Galvani Bioelectronics to develop a solid state
battery for miniature medical implants. Ilika's Stereax(TM)
batteries have a high power density, a long battery life and they
can be produced in miniature form, making them particularly
suitable for these micro-devices.
This collaboration aims to deliver key components of
bioelectronic devices, which have the potential to provide
treatments for serious health conditions, through the body's own
nervous system.
The GBP1.0 million development project is supported by funding
of GBP0.7 million, which Ilika will receive from Innovate UK and
the Medical Research Council.
Commenting on this grant award, Graeme Purdy, Ilika CEO, said:
"This partnership with Galvani Bioelectronics, using Ilika's
lithium-ion Stereax battery technology, may provide the potential
to treat diseases that have so far been difficult to manage.
Collaborations like this are critical to the delivery of advances
in the field of solid state battery development."
For more information, contact:
Ilika plc www.ilika.com
Graeme Purdy, Chief Tel: 023 8011 1400
Executive
Steve Boydell, Finance
Director
Numis Securities Limited Tel: 020 7260 1000
Oliver Cardigan/ Paul
Gillam /
James Black
Walbrook PR Ltd Tel: 020 7933 8780 / ilika@walbrookpr.com
Paul Cornelius Mob: 07866 384 707
Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCJJMFTMBMBBFR
(END) Dow Jones Newswires
March 14, 2017 03:00 ET (07:00 GMT)
Ilika (LSE:IKA)
Historical Stock Chart
From Apr 2024 to May 2024
Ilika (LSE:IKA)
Historical Stock Chart
From May 2023 to May 2024
